FMR LLC boosted its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 34.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 133,844 shares of the company's stock after acquiring an additional 34,421 shares during the period. FMR LLC owned approximately 0.29% of Avanos Medical worth $3,216,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AVNS. KBC Group NV lifted its holdings in shares of Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after purchasing an additional 1,095 shares in the last quarter. Canada Pension Plan Investment Board bought a new stake in shares of Avanos Medical in the second quarter valued at about $70,000. XTX Topco Ltd bought a new stake in shares of Avanos Medical in the second quarter valued at about $202,000. Intech Investment Management LLC bought a new stake in shares of Avanos Medical in the third quarter valued at about $207,000. Finally, Magnetar Financial LLC bought a new stake in shares of Avanos Medical in the second quarter valued at about $248,000. 95.17% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com lowered Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd.
Check Out Our Latest Stock Report on Avanos Medical
Avanos Medical Stock Performance
NYSE AVNS traded down $0.47 during trading on Friday, reaching $17.97. 421,445 shares of the company's stock were exchanged, compared to its average volume of 245,104. The business has a 50 day moving average price of $20.27 and a 200-day moving average price of $21.43. The stock has a market capitalization of $825.90 million, a P/E ratio of 52.85 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical, Inc. has a fifty-two week low of $17.39 and a fifty-two week high of $25.36.
About Avanos Medical
(
Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
